Atracurium besylate
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
1243.49
Molecular Formula
C65H82N2O18S2
Notes
Research use only, not for human use.
Receptor
NAChR
CAS Number
64228-81-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1032735-01 0.02 mg (E-Coli)
Recombinant Orientia tsutsugamushi Triosephosphate isomerase (tpiA)
Ask
View Details 
MBS1032735-02 0.1 mg (E-Coli)
Recombinant Orientia tsutsugamushi Triosephosphate isomerase (tpiA)
Ask
View Details MBS1032735-03 0.02 mg (Yeast)
Recombinant Orientia tsutsugamushi Triosephosphate isomerase (tpiA)
Ask
View Details 
MBS1032735-04 0.1 mg (Yeast)
Recombinant Orientia tsutsugamushi Triosephosphate isomerase (tpiA)
Ask
View Details MBS1032735-05 0.02 mg (Baculovirus)
Recombinant Orientia tsutsugamushi Triosephosphate isomerase (tpiA)
Ask
View Details MBS1032735-06 0.02 mg (Mammalian-Cell)
Recombinant Orientia tsutsugamushi Triosephosphate isomerase (tpiA)
Ask
View Details